Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials
2018; Oxford University Press; Volume: 218; Issue: 1 Linguagem: Inglês
10.1093/infdis/jiy112
ISSN1537-6613
AutoresMahboobeh Safaeian, Xavier Castellsagué, Allan Hildesheim, Sholom Wacholder, Mark Schiffman, Marie‐Cécile Bozonnat, Laurence Baril, Dominique Rosillon, Archana Chatterjee, S-N Chow, Nathalie De Carvalho, Del Rosario Raymundo, Francisco Díaz‐Mitoma, Gary Dubin, Suzanne M. Garland, Maria Julieta V. Germar, Paula González, Diane M. Harper, Unnop Jaisamrarn, Aimée R. Kreimer, Matti Lehtinen, Paulo Naud, Jorma Paavonen, Klaus Peters, W Poppe, Carolina Porras, Jorge Salmerón, Mark E. Sherman, S. Rachel Skinner, Frank Struyf, Júlio César Teixeira, Wiebren Tjalma, Cosette M. Wheeler,
Tópico(s)Herpesvirus Infections and Treatments
ResumoStudies on the role of antibodies produced after infection with human papillomavirus 18 (HPV-18) and subsequent protection from HPV-18 infection have been conflicting, mainly due to inadequate sample size.
Referência(s)